Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab

Dermatol Ther. 2022 Nov;35(11):e15839. doi: 10.1111/dth.15839. Epub 2022 Sep 23.

Authors

Matteo Megna¹, Lucia Genco¹, Matteo Noto¹, Cataldo Patruno², Gabriella Fabbrocini¹, Maddalena Napolitano³

Affiliations

¹ Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
² Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy.
³ Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise, Campobasso, Italy.

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized
Eczema* / drug therapy
Humans
Psoriasis*
Severity of Illness Index
Treatment Outcome

Substances

guselkumab
dupilumab
brodalumab
Antibodies, Monoclonal, Humanized